Medpace
MEDPMedpace has retired 31.5% of its shares since 2016, from 40,728,022 to 27,911,655.
31.5%retired since 2016
22.3%last 5 years
0.9%last 12 months
28Mshares today
Medpace has retired 31.5% of its shares since 2016, from 40,728,022 to 27,911,655.
| Fiscal year | Date | Shares outstanding | Filing | |
|---|---|---|---|---|
| 2016 | 2017-02-24 | 40,728,022 | 10-K | |
| 2017 | 2018-02-23 | 35,484,924 | 10-K | |
| 2018 | 2019-02-22 | 35,688,784 | 10-K | |
| 2019 | 2020-02-21 | 36,092,497 | 10-K | |
| 2020 | 2021-02-12 | 35,734,291 | 10-K | |
| 2021 | 2022-02-11 | 35,228,722 | 10-K | |
| 2022 | 2023-02-10 | 31,050,160 | 10-K | |
| 2023 | 2024-02-09 | 30,759,281 | 10-K | |
| 2024 | 2025-02-07 | 30,466,806 | 10-K | |
| 2025 | 2026-02-06 | 28,381,283 | 10-K |
Source: all 10-K filings of Medpace on EDGAR. Download this series as CSV. Licence CC BY 4.0, credit Buyback Radar.
Loading the chart from TradingView…
All-time chart by TradingView. Open it on TradingView →
Yes. Medpace has 0.9% fewer shares outstanding than twelve months ago, 27,911,655 as of July 17, 2026. Over five years the share count is down 22.3%.
Net of every new share it issued, Medpace has 12.8 million fewer shares than at its 2016 peak. That is 31.5% of the company.
27,911,655 shares, as of July 17, 2026, from the cover page of its latest 10-Q. At the 2016 peak it had 40,728,022.
Each share is a bigger slice of the company. Someone who held Medpace stock in 2016 owns 1.5 times as much of the business today without buying another share. Whether that was a good use of cash depends on the price paid.
Medpace ranks No. 165 of 251 companies on Buyback Radar by share of the company retired since its peak. Close to it on the list: Alpha Metallurgical (31.6%), Willis Towers Watson (31.5%), Vistra (31.2%), Corebridge Financial (31.2%).
Every answer is computed from Medpace's own SEC filings and rebuilt every Monday. Latest count: 10-Q on EDGAR.
From the latest 13F filings. All superinvestors.
The numbers say what happened. The story says whether it can continue. We cover companies like Medpace in depth on Cannibal Stocks.
Read Cannibal Stocks